NCC Medical Group is a globally recognized manufacturer specializing in advanced neurodiagnostic and neuro-monitoring technologies. With more than two decades of experience in the neurophysiology industry, NCC has established itself as a trusted provider of high-performance EEG medical device solutions, intraoperative neuromonitoring systems, electromyography platforms, and neurological medical consumables.
Founded in 1997, NCC has built a comprehensive innovation ecosystem that integrates research, manufacturing, and global service support. The company’s primary research and manufacturing center is located in Shanghai, China, a leading hub for advanced medical technology development. This facility houses state-of-the-art laboratories, precision production lines, and specialized engineering teams dedicated to the development of next-generation EEG medical device systems and neurodiagnostic equipment.
To ensure global regulatory compliance and product quality, NCC operates a dedicated quality and compliance center in Singapore. This international hub oversees global certification, regulatory affairs, and quality management processes, ensuring that every EEG medical device meets international standards for safety, reliability, and clinical performance.
NCC has been recognized as a National “Little Giant” enterprise under the SRDI program—Specialized, Refined, Differential, and Innovational. This prestigious designation is awarded by the government to companies with strong innovation capability and core patented technologies. Through continuous investment in research and development, NCC has successfully developed multiple generations of EEG medical device platforms that support advanced clinical applications and scientific research.
The company’s product portfolio covers a wide range of neurophysiology solutions including EEG, polysomnography (PSG), electromyography (EMG), and intraoperative neuromonitoring (IONM). These technologies are widely used in neurology departments, sleep laboratories, intensive care units, and research institutions around the world.
NCC’s global distribution network spans more than 50 countries and regions. Its clinical solutions are deployed in over 5,000 hospitals across China and are increasingly adopted by medical institutions in Southeast Asia, Australia, Europe, the Americas, and Africa. By collaborating with international distributors and clinical partners, NCC continues to expand the global reach of its EEG medical device technologies.
A key component of NCC’s service strategy is the NeuGuard Service Platform and the NCC Innovation Academy. These programs provide comprehensive training, technical support, and continuous professional education for clinicians and biomedical engineers. With 31 training and technical support centers across China, NCC ensures that healthcare providers receive the knowledge and assistance needed to fully utilize advanced EEG medical device systems.
NCC’s mission is to safeguard life and health by advancing safer surgeries, precise neurological diagnostics, and high-quality patient care. Through continuous innovation, global collaboration, and dedicated customer support, NCC Medical Group remains committed to delivering cutting-edge EEG medical device solutions that empower healthcare professionals worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy